MOPP(redirected from Oncovorin)
Acronym for mechlorethamine, Oncovin (vincristine), procarbazine, and prednisone, a chemotherapy regimen used in the treatment of Hodgkin disease.
MOPPa cancer chemotherapy regimen consisting of mechlorethamine, Oncovin (vincristine), procarbazine, and prednisone.
abbreviation for a combination drug regimen used in the treatment of cancer, containing three antineoplastics, Mustargen (mechlorethamine hydrochloride), Oncovin (vinCRIStine sulfate), Matulane (procarbazine hydrochloride), and predniSONE (a glucocorticoid). MOPP is prescribed in the treatment of Hodgkin's disease.
MOPPA 4-drug chemotherapy regimen for stage-III Hodgkin lymphoma.
Sterility, nausea, vomiting, immunosuppression, increased infections, myelosuppression, myelodysplasia, ANLL.
MOPPMechlorethamine–nitrogen mustard, vincristine–Oncovorin, Procarbazine, Prednisone Oncology A 4-drug chemotherapy regimen for stage III Hodgkin's disease Adverse effects Sterility, N&V, immunosuppression, ↑ infections, 2º myelosuppression, myelodysplasia, ANLL. See Chemotherapy, Hodgkin's disease.
Acronym for mission-oriented protective posture
a regimen of mechlorethamine (mustine), Oncovin (vincristine), procarbazine and prednisone, used in cancer chemotherapy.